The diabetes products alliance between multinationals drug-makers Eli Lilly and Boehringer Ingelheim is set to roll out its first new product under the alliance.
Next week, Boehringer Ingelheim’s oral product Linagliptin will be available at chemists.
The product would be priced at Rs 42.70 per dose, per day.
http://www.thehindubusinessline.com/companies/article3527539.ece?homepage=true
No comments:
Post a Comment